A Registry-Based, Observational Safety Study Of Inotuzumab Ozogamicin (Ino) In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia (All) Proceeding To Hematopoietic Stem Cell Transplant (Hsct)
Inotuzumab ozogamicin
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Registry-Based, Observational Safety Study Of Inotuzumab Ozogamicin (Ino) In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia (All) Proceeding To Hematopoietic Stem Cell Transplant (Hsct) ### Output: Inotuzumab ozogamicin